Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast

Conclusion: Patient risk profiles rationally affect treatment choice in DCIS patients, and the vast majority of high-risk patients do not receive CS alone. Additional follow up is needed to determine whether geographic variation in care influences long-term outcomes.